NCT06987071

Brief Summary

This randomized controlled trial evaluates the efficacy of acupuncture in reducing pain and improving patient experience during transperineal prostate biopsy. Participants will be randomized to receive either acupuncture or sham acupuncture prior to the biopsy, in addition to standard local anesthesia. The primary outcome is pain, measured using the Visual Analog Scale (VAS), while secondary outcomes include anxiety, additional analgesic use, patient satisfaction, and adverse events.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
72

participants targeted

Target at P25-P50 for not_applicable prostate-cancer

Timeline
Completed

Started Jul 2025

Shorter than P25 for not_applicable prostate-cancer

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 7, 2025

Completed
16 days until next milestone

First Posted

Study publicly available on registry

May 23, 2025

Completed
2 months until next milestone

Study Start

First participant enrolled

July 15, 2025

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2025

Completed
19 days until next milestone

Study Completion

Last participant's last visit for all outcomes

October 20, 2025

Completed
Last Updated

November 21, 2025

Status Verified

November 1, 2025

Enrollment Period

3 months

First QC Date

May 7, 2025

Last Update Submit

November 18, 2025

Conditions

Keywords

acupunctureprostate cancertransperineal prostat biopsyacupuncture anesthesia

Outcome Measures

Primary Outcomes (1)

  • Pain Score

    Visual Analog Scale (VAS), a 0-10 scale where 0 represents no pain and 10 represents the worst pain imaginable.

    Baseline, perioperative, 30 minutes post-biopsy, 2 hours post-biopsy.

Secondary Outcomes (3)

  • Anxiety Level

    before and after 30 minutes of operation

  • Additional Analgesic Use

    after biopsy in 8 hours

  • Adverse events

    peri operative

Study Arms (2)

Acupuncture

ACTIVE COMPARATOR

Participants receive acupuncture at specific points (LI4, PC6, ST36, SP6) for 20 minutes with manual stimulation, 30 minutes before the biopsy, alongside standard local anesthesia.

Procedure: Acupuncture

Sham Acupuncture

SHAM COMPARATOR

Participants receive superficial needle insertion at non-acupuncture points without stimulation, 30 minutes before the biopsy, alongside standard local anesthesia.

Procedure: sham acupuncture

Interventions

AcupuncturePROCEDURE

Insertion of sterile, single-use needles at specific acupuncture points (LI4, PC6, ST36, SP6) for 20 minutes with manual stimulation, administered 30 minutes before the biopsy by a licensed acupuncturist.

Acupuncture

Superficial needle insertion at non-acupuncture points without stimulation, administered 30 minutes before the biopsy, mimicking the acupuncture procedure without therapeutic intent.

Sham Acupuncture

Eligibility Criteria

Age40 Years - 75 Years
Sexmale(Gender-based eligibility)
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Indicated for transperineal prostate biopsy (e.g., elevated PSA, abnormal digital rectal exam).
  • Willing and able to provide written informed consent.

You may not qualify if:

  • Known allergy or contraindication to acupuncture (e.g., bleeding disorder, needle phobia).
  • Requirement for sedation or general anesthesia.
  • Previous experience with acupuncture treatment.
  • Severe psychiatric disorders or diagnosed anxiety disorder.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

İstanbul Başakşehir Çam ve sakura City Hospita

Istanbul, Turkey (Türkiye)

Location

Related Publications (4)

  • Hong A, Hemmingway S, Wetherell D, Dias B, Zargar H. Outpatient transperineal prostate biopsy under local anaesthesia is safe, well tolerated and feasible. ANZ J Surg. 2022 Jun;92(6):1480-1485. doi: 10.1111/ans.17593. Epub 2022 Mar 10.

  • Yang J, Xiong X, Wei Q, Yang L. Acupuncture: a promising adjuvant strategy for pain management among the patients with prostate cancer. BJU Int. 2024 Oct;134(4):664-665. doi: 10.1111/bju.16467. Epub 2024 Jul 17. No abstract available.

  • Lin FX, Chen Y, Xu ZP. Enhancing perioperative pain management: the integrative potential of acupuncture in urological surgery. BJU Int. 2024 Oct;134(4):667-668. doi: 10.1111/bju.16503. Epub 2024 Aug 6. No abstract available.

  • Wang J, Lei Y, Bao B, Yu X, Dai H, Chen F, Li H, Wang B. Acupuncture for pain caused by prostate cancer: Protocol for a systematic review. Medicine (Baltimore). 2019 Jan;98(2):e13954. doi: 10.1097/MD.0000000000013954.

MeSH Terms

Conditions

Prostatic NeoplasmsAgnosia

Interventions

Acupuncture Therapy

Condition Hierarchy (Ancestors)

Genital Neoplasms, MaleUrogenital NeoplasmsNeoplasms by SiteNeoplasmsGenital Diseases, MaleGenital DiseasesUrogenital DiseasesProstatic DiseasesMale Urogenital DiseasesPerceptual DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Complementary TherapiesTherapeutics

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: This is a randomized, single-blind, parallel-group trial. Participants are randomly assigned in a 1:1 ratio to receive either acupuncture or sham acupuncture 30 minutes prior to transperineal prostate biopsy. Both groups receive standard local anesthesia. Randomization is performed using a computer-generated sequence, and outcome assessors are blinded to group assignments.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD

Study Record Dates

First Submitted

May 7, 2025

First Posted

May 23, 2025

Study Start

July 15, 2025

Primary Completion

October 1, 2025

Study Completion

October 20, 2025

Last Updated

November 21, 2025

Record last verified: 2025-11

Locations